migraines

Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Fierce Pharma
Mon, 08/10/20 - 10:52 pm
Teva Pharmaceutical
migraines
Ajovy
autoinjectors
Amgen
Eli Lilly
Biohaven hits social media jackpot with superceleb Khloe Kardashian as spokesperson for migraine med Nurtec ODT
Fierce Pharma
Thu, 07/16/20 - 11:22 pm
Biohaven
migraines
social media
celebrity endorsements
Nurtec ODT
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Fierce Pharma
Thu, 06/25/20 - 10:53 am
migraines
physicians
Biohaven
Eli Lilly
AbbVie
Nurtec ODT
Ubrelvy
Reyvow
Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'
Fierce Pharma
Wed, 06/17/20 - 09:52 pm
Eli Lilly
migraines
Amgen
Teva Pharmaceutical
Lundbeck
Emgality
Will a Migraine Drug Save This Debt-Ridden Giant?
Motley Fool
Tue, 05/5/20 - 10:51 am
Teva Pharmaceutical
Ajovy
FDA
migraines
Axsome celebrates migraine PhIII win, shifting eyes toward a pair of Q4 submissions
Endpoints
Mon, 04/6/20 - 10:36 am
Axsome
clinical trials
migraines
AXS-05
Biohaven embraces digital to keep migraine launch on track despite COVID-19
Fierce Pharma
Wed, 03/25/20 - 11:54 pm
Biohaven
migraines
drug launches
digital pharma
COVID-19
pandemic
Nurtec
Reyvow, Migraine Drug That Treats Pain In Hours, Now Hits The Shelves
Forbes
Sat, 02/29/20 - 06:50 pm
Reyvow
migraines
drug launches
Eli Lilly
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Thu, 02/27/20 - 11:46 pm
Biohaven
FDA
migraines
Nurtec
Allergan
AbbVie
Ubrelvy
In final report, ICER appears to have a change of heart on new acute migraine therapies
Endpoints
Tue, 02/25/20 - 10:40 am
ICER
migraines
Biohaven
Allergan
ubrogepant
rimegepant
Eli Lilly
Lasmiditan
The fourth CGRP migraine drug is here. Time for Lundbeck to prove it's worth $2B
Endpoints
Sat, 02/22/20 - 11:29 pm
Lundbeck
eptinezumab
migraines
CGRPs
Vyepti
Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst
Fierce Pharma
Fri, 02/21/20 - 10:49 am
Allergan
Botox
migraines
physicians
neurologists
CGRPs
Saniona Co-Founds New Migraine-Focused Company
BioSpace
Tue, 02/18/20 - 08:33 pm
Saniona
migraines
Denmark
Cephagenix
Lilly's migraine reliever Reyvow cleared for launch, beating Allergan's rival Ubrelvy to market
Fierce Pharma
Fri, 01/31/20 - 12:14 pm
migraines
Eli Lilly
Reyvow
Allergan
Ubrelvy
Teva's Ajovy finally gets its autoinjector nod. Can it close the gap with Amgen, Lilly meds?
Fierce Pharma
Wed, 01/29/20 - 10:45 am
Teva Pharmaceutical
Ajovy
migraines
autoinjectors
FDA
CGRPs
Migraine, cholesterol upstarts top the list of FDA decisions to watch this quarter
Fierce Pharma
Fri, 01/3/20 - 11:03 pm
FDA
migraines
cholesterol
Epizyme
tazemetostat
Esperion
bempedoic acid
teprotumumab
Horizon Therapeutics
Biohaven
rimegepant
Allergan scores year-end FDA nod for CGRP migraine med Ubrelvy, plans early 2020 launch
Fierce Pharma
Mon, 12/23/19 - 11:56 pm
Allergan
UIbrelvy
ubrogepant
FDA
migraines
CGRPs
Lilly launches real-world study to benchmark Emgality against migraine rivals
Fierce Pharma
Wed, 12/18/19 - 11:54 pm
Eli Lilly
migraines
Emgality
real world evidence
RWE
3 Biotechs Facing FDA Approvals by Year's End
Motley Fool
Mon, 12/9/19 - 09:45 am
FDA
Amgen
Vascepa
Allergan
migraines
ubrogepant
Intra-Cellular Therapies
lumateperone
schizophrenia
Go or no go? Vascepa’s finale and Allergan's pain relief
EP Vantage
Mon, 12/2/19 - 10:37 am
FDA
Amarin
Vascepa
Allergan
migraines
ubrogepant

Pages